JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.R400024200 on September 13, 2004

J. Biol. Chem., Vol. 279, Issue 50, 51715-51718, December 10, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/50/51715    most recent
R400024200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Geiszt, M.
Right arrow Articles by Leto, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Geiszt, M.
Right arrow Articles by Leto, T. L.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Minireview

The Nox Family of NAD(P)H Oxidases: Host Defense and Beyond*

Miklós Geiszt{ddagger} and Thomas L. Leto§

From the {ddagger}Department of Physiology, Semmelweis University, Faculty of Medicine, H-1444 Budapest, Hungary and §Laboratory of Host Defenses, NIAID, National Institutes of Health, Bethesda, Maryland 20892


   INTRODUCTION
TOP
 INTRODUCTION
NAD(P)H Oxidase 1 (Nox1)
 NAD(P)H Oxidase 3 (Nox3)
 NAD(P)H Oxidase 4 (Nox4)
 NAD(P)H Oxidase 5 (Nox5)
 Dual Oxidases (Duox1 and...
 Functional Partners of Nox...
 Conclusion
 REFERENCES
 
Reactive oxygen species (ROS)1 play diverse roles in biology, including host defense, hormone biosynthesis, fertilization, and redox signaling involved in mitogenesis, apoptosis, or oxygen sensing. Until recently, much of our understanding of the mechanisms of ROS generation and their functions in man was based on studies of phagocytic cells, where abundant microbicidal oxidants released during engulfment of microbes serve as a first line of host defense. In phagocytic cells the ROS precursor superoxide is produced by a NADPH oxidase complex (1–3). The phagocytic oxidase (phox) consists of a membrane-bound flavocytochrome b558, several modular cytosolic regulators (p47phox, p67phox, p40phox), and a small GTPase, Rac1 or Rac2. The cytochrome is a complex of two proteins: a flavin- and heme-binding glycoprotein (gp91phox) and a smaller subunit (p22phox). With the recent expansion of information available in human genome databases, several novel gp91phox homologues have been recognized (Fig. 1), suggesting that enzymes similar to the phagocytic oxidase function in a variety of tissues, notably the colon, kidney, thyroid gland, testis, salivary glands, airways, and lymphoid organs (4–9). The physiological functions of these novel NADPH oxidases, now designated the Nox family, are currently under intensive investigation. Recent reviews have described in detail the molecular features of the phox system (2, 3). This review updates our current knowledge about novel members of the Nox family.



View larger version (35K):
[in this window]
[in a new window]
  		FIG. 1.
Topology of Nox family NAD(P)H oxidase with respect to the membrane. All members share features in common with those originally characterized in the core component of the phagocytic oxidase, gp91phox or Nox2 (reviewed in Refs. 1–3); these include six hydrophobic, membrane-spanning segments and several conserved motifs involved in binding NAD(P)H, FAD, and two heme moieties. Nox5 has an additional four calcium-binding EF-hands, whereas the dual oxidases (Duox1 and -2) have two EF-hands and an extracellular peroxidase homology domain.

 

   NAD(P)H Oxidase 1 (Nox1)
TOP
 INTRODUCTION
 NAD(P)H Oxidase 1 (Nox1)
NAD(P)H Oxidase 3 (Nox3)
 NAD(P)H Oxidase 4 (Nox4)
 NAD(P)H Oxidase 5 (Nox5)
 Dual Oxidases (Duox1 and...
 Functional Partners of Nox...
 Conclusion
 REFERENCES
 
Nox1, the first recognized homologue of gp91phox, now termed Nox2, is detected in abundance in the colon and at lower levels in uterus, prostate, and vascular smooth muscle cells (4). The 564-amino acid protein is 56% identical to gp91phox and contains the essential features of its phagocytic counterpart, including six transmembrane segments and several conserved motifs considered important for binding of NADPH, FAD, and two heme molecules. Two variants of the full-length isoform have been described. Bánfi et al. (10) isolated a short mRNA product of the Nox1 gene encoding a proton-conductive channel, called NOH-1S (10). They suggested that a unique intraexonic splicing process gives rise to the NOH-1S-coding mRNA. Recent studies showed, however, that the NOH-1S product is not transcribed from the Nox1 gene but is artifactually derived by intramolecular template switching during reverse transcription.2 Although RNA splicing does not account for NOH-1S synthesis, RNA splicing does generate another Nox1 transcript in normal colon and in colon carcinoma cells, where it is nearly as abundant as the full-length transcript. This transcript lacks the entire exon 11 (residues 433–482) and does not encode a functional oxidase2 (10).

In early work exploring the function of Nox1, heterologous overexpression of Nox1 in NIH-3T3 cells was associated with increased cell proliferation and resulted in tumor formation when these cells were injected into nude mice (4). Subsequent reports proposed that hydrogen peroxide (H2O2) formation in these Nox1-expressing cells is responsible for the increased mitogenesis (11). These findings were enthusiastically received because enhanced cellular ROS generation has been linked to the enhanced growth triggered by growth factor stimulation or tumorigenesis (12–14). Cells overexpressing Nox1 also showed increased vascular endothelial growth factor expression, suggesting that ROS produced by Nox1 also stimulates angiogenesis in these tumors (15). Further studies revealed, however, that these Nox1-transfected NIH-3T3 cell lines also carry a mutant form of Ras that can account for the enhanced proliferation and transformation (16). Observations in colon-derived epithelial cells, which naturally express Nox1, do not support the proposed role of Nox1 as a mitogenic oxidase. In HT29 colon cancer cells, the suppression of Nox1 levels does not affect cell proliferation (17). Furthermore, significantly higher Nox1 expression occurs when HT29 or CaCo2 cells are induced to differentiate by interferon-{gamma} or by calcitriol (17). Finally, a survey of various human cancerous tissues showed Nox1 expression is limited to colon tumors and the highest Nox1 expression occurs in more differentiated tumors (17). Together, these findings suggest that Nox1 serves some other specialized function in differentiated colon epithelium unrelated to mitogenesis.

Several observations suggest that Nox1 could serve as a host defense oxidase. Nox1 induction, along with increased ROS release, was detected in guinea pig gastric pit cells primed with Helico-bacter pylori lipopolysaccharides (LPS) (18). Kawahara et al. (19) proposed that LPS from pathogenic H. pylori strains potently stimulates ROS production through a toll-like receptor 4 (TLR4) pathway. In contrast, colon epithelial cells, which lack TLR4 receptors and do not respond to LPS, exhibit high Nox1-mediated ROS production in response to flagellin from Salmonella enteritides, acting through TLR5-dependent pathways (19). A role for Nox1 in innate immunity was also suggested by experiments showing that Nox1 could replace Nox2 (gp91phox) in the regulated production of superoxide, thereby partially rescuing the deficiency in superoxide production observed in chronic granulomatous disease neutrophils (17). Together, these findings demonstrate that Nox1 is functionally similar to gp91phox/Nox2. Whether Nox1 has a primary role in maintaining colon epithelial integrity or in host defense will require further investigation.

Although few reports have explored the role of Nox1 in the colon, where it is most abundant, several groups have examined the possible involvement of Nox1 in ROS production in vascular tissue. Nox1 expression in cultured smooth muscle cells was described by Suh et al. (4), and several other groups confirmed these findings (reviewed in Ref. 20). Several agonists, including platelet-derived growth factor, angiotensin II, and prostaglandin F2{alpha}, appear to up-regulate Nox1 mRNA levels in cultured smooth muscle cells (4, 21, 22), whereas suppression of Nox1 expression by antisense techniques inhibited superoxide production (4). Thus, production of ROS by Nox1 in these cells could have roles in angiotensin II- and growth factor-induced cell hypertrophy or proliferation. Future studies on knock-out and other transgenic animals should provide better insight into the role of Nox1 in vascular tissue.


   NAD(P)H Oxidase 3 (Nox3)
TOP
 INTRODUCTION
 NAD(P)H Oxidase 1 (Nox1)
 NAD(P)H Oxidase 3 (Nox3)
NAD(P)H Oxidase 4 (Nox4)
 NAD(P)H Oxidase 5 (Nox5)
 Dual Oxidases (Duox1 and...
 Functional Partners of Nox...
 Conclusion
 REFERENCES
 
Nox3, a 568-amino acid protein, also has close similarities to gp91phox/Nox2 (58% sequence identity) (23). Nox3 mRNA was not detected in adult or in fetal tissues by Northern blotting; however, reverse transcription-PCR experiments detected Nox3 mRNA in several fetal tissues, including kidney, liver, lung, and spleen (23, 24). Recently, a unique role for this oxidase within the inner ear was revealed by positional cloning studies that mapped genetic lesions causing the head tilt (het) phenotype in mice (25). Mice with Nox3 mutations exhibit impaired otoconial morphogenesis and defects in perception of gravity and balance. It was proposed that this oxidase mediates ROS-dependent conformation changes in otoconin 90 involved in the nucleation of calcite crystal formation during the development of otoconia.


   NAD(P)H Oxidase 4 (Nox4)
TOP
 INTRODUCTION
 NAD(P)H Oxidase 1 (Nox1)
 NAD(P)H Oxidase 3 (Nox3)
 NAD(P)H Oxidase 4 (Nox4)
NAD(P)H Oxidase 5 (Nox5)
 Dual Oxidases (Duox1 and...
 Functional Partners of Nox...
 Conclusion
 REFERENCES
 
Nox4, a 578-amino acid protein with 39% sequence identity to gp91phox/Nox2 was originally described as a renal oxidase (Renox) because its expression at high levels is limited to the kidney (5, 8). However, the specific intrarenal distribution of Nox4 mRNA differs significantly in mice and humans. In situ hybridization in mouse kidney sections demonstrated the highest levels in proximal tubules (5), whereas immunohistochemical and in situ hybridization studies on human kidneys detected Nox4 expression in distal portions of the nephron3 (8). When overexpressed in NIH-3T3 fibroblasts, Nox4 increased superoxide production and induced a cellular senescence phenotype (5, 8). Expression of antisense Nox4 mRNA in HEK293 cells, which contain endogenous Nox4, resulted in a decreased NADH- and NADPH-dependent superoxide production in vitro (8). The expression pattern of Nox4 is consistent with several renal-specific functions. One proposed role in oxygen sensing and regulation of erythropoietin (EPO) synthesis (5, 8) is based on several findings. The phagocyte cell homologue of Nox4, gp91phox/Nox2, was described as an oxygen sensor in the lung (26). In the kidney, EPO synthesis also occurs in proximal tubules (27), and ROS are implicated as negative feedback signals regulating EPO synthesis (28). Although the hypoxia-inducible factor-1{alpha}, which regulates EPO synthesis, is regulated by proline hydroxylases (29), other hypoxia-inducible factor-1{alpha}-independent transcription factors, such as GATA-2, are direct H2O2-sensitive targets that suppress EPO expression (30). Finally, recent knock-out studies indicate that superoxide dismutase 3, which is also expressed in renal proximal tubules, has a role in erythroid responses to hypoxia (31). These observations along with the high constitutive activity of Nox4 (5, 8) are consistent with a role for Nox4 in oxygen sensing.

A distinct possibility related to high renal Nox4 expression is that it serves as a phox-like antimicrobial system by releasing ROS into the glomerular filtrate; this might explain significant (i.e. 100 µM) urinary hydrogen peroxide levels (32). Other possible functions of the renal oxidase include roles in oxidation or detoxification of urine wastes or in renal pH or electrolyte homeostasis, based on the proton-generating and electrogenic activities of all NADPH oxidases. Finally, Gorin et al. (33) suggested that a Nox4-based oxidase is stimulated in response to angiotensin II in mesangial cells.

Several groups have also explored possible extra-renal functions of Nox4. According to Yang et al. (34), Nox4 and gp91phox (Nox2) are present in murine osteoclasts, where they may provide an oxidative basis for bone resorption. Low Nox4 expression is detected in vascular smooth muscle cells, where it appears to be down-regulated by agonists that increase Nox1 expression (21). Although the relative contribution of Nox4 to vascular ROS production remains unclear, Nox4 was also suggested as the major component of an endothelial NAD(P)H oxidase (35). In several cell lines, growth factor or insulin receptor stimulation increases ROS production, which has an enhancing effect on tyrosine phosphorylation in part through inhibition of protein-tyrosine phosphatases (36). A recent study indicates that Nox4 mediates insulin-stimulated ROS production in 3T3-L1 adipocytes (37). Further studies in gene-targeted animals may confirm roles for Nox4 in insulin signaling.


   NAD(P)H Oxidase 5 (Nox5)
TOP
 INTRODUCTION
 NAD(P)H Oxidase 1 (Nox1)
 NAD(P)H Oxidase 3 (Nox3)
 NAD(P)H Oxidase 4 (Nox4)
 NAD(P)H Oxidase 5 (Nox5)
Dual Oxidases (Duox1 and...
 Functional Partners of Nox...
 Conclusion
 REFERENCES
 
NADPH oxidase 5 (Nox5) is more distantly related to the other Nox proteins, with an overall homology to gp91phox of 27% (9). The protein consists of 737 amino acids and contains an additional N-terminal extension comprising four calcium-binding, EF-hand motifs that appear to render the enzyme directly responsive to calcium. Superoxide production by Nox5-expressing cells is induced by the calcium ionophore ionomycin (9). Recent work demonstrated that the EF-hands engage in direct, calcium-dependent interactions with the C-terminal domain of Nox5 (38). In testis, Nox5 mRNA was detected in pachytene spermatocytes (9), raising the possibility that it may function in mature spermatozoa, such as in oxidative changes associated with human sperm capacitation or the acrosome reaction (39). In the spleen, Nox5 message localizes to the mantle zone surrounding germinal centers (areas rich in B cells) and to periarterial lymphoid sheets (where mostly T cells are present) (9). T and B lymphocytes produce ROS when stimulated by some receptor agonists (40, 41). A role for Nox5 in cell proliferation was suggested by Brar et al. (42), who demonstrated that antisense oligonucleotide-mediated down-regulation of Nox5 expression in DU 145 prostate cancer cells inhibits cell proliferation.


   Dual Oxidases (Duox1 and Duox2)
TOP
 INTRODUCTION
 NAD(P)H Oxidase 1 (Nox1)
 NAD(P)H Oxidase 3 (Nox3)
 NAD(P)H Oxidase 4 (Nox4)
 NAD(P)H Oxidase 5 (Nox5)
 Dual Oxidases (Duox1 and...
Functional Partners of Nox...
 Conclusion
 REFERENCES
 
Dual oxidases, originally designated thyroid oxidases (thOX or tox), were cloned from human and porcine thyroid glands and proposed to serve in iodide organification during thyroxine synthesis (6, 7). The Duox (dual oxidase) nomenclature was suggested (43) as these proteins contain an N-terminal extracellular peroxidase-like domain and a gp91phox-like oxidase portion (6, 7, 43). Human Duox1 and Duox2 proteins contain 1551 and 1548 amino acids, respectively, and show 83% sequence similarity. Separating the peroxidase-like domain and the NADPH oxidase portion are an additional transmembrane segment and two EF-hand motifs (Fig. 1). The peroxidase-like domains of Duox proteins are unusual in that they lack conserved histidine residues found in all other peroxidases, considered essential for heme binding (44). The presence of EF-hands suggests that calcium directly regulates these enzymes, consistent with early observations showing that calcium ionophores stimulate H2O2 production in thyroid cells (45). Heterologous Duox expression in several mammalian cell lines fails to reconstitute ROS release, suggesting other tissue-specific oxidase components are needed for Duox activity (46).

In thyroid follicles, the Duox proteins are detected on the thyrocyte apical surface, where they could supply H2O2 for thyroperoxidase-mediated iodination and cross-linking of thyroglobulin tyrosine residues. Duox2 is clearly essential for thyroxine biosynthesis because Duox2 mutations result in congenital hypothyroidism, even in heterozygotes (47). The role of Duox1 in thyroid tissue has not been clarified. Duox proteins are also encoded by the genomes of lower species, such as Caenorhabditis elegans (43). Defective cuticle formation was observed during C. elegans development following inhibition of Duox expression by RNA interference (43). It was proposed that Duox provides the ROS for oxidative cross-linking of extracellular matrix tyrosine residues in a reaction thought to involve the extracellular peroxidase-like domain. The isolated C. elegans peroxidase-like domain produced in Escherichia coli appears to catalyze cross-linking of tyrosine residues in vitro (43).

Novel roles for Duox enzymes in host defense were recently proposed in several non-thyroid tissues (48). Based on the high levels of Duox in epithelial cells of salivary gland ducts and along mucosal surfaces of colon, rectum, and major airways, these enzymes were proposed to serve as sources of H2O2 supporting the anti-microbial activity of lactoperoxidase. Lactoperoxidase, abundant in milk, saliva, tears, and mucosal secretions, uses H2O2 to oxidize thiocyanate to hypothiocyanite, an oxidant effective against both Gram-negative and Gram-positive bacterial species (49). Thus, the dual oxidases may represent "missing links" that complete an oxidant-dependant microbicidal system that has been long recognized in many body fluids.


   Functional Partners of Nox Isoforms
TOP
 INTRODUCTION
 NAD(P)H Oxidase 1 (Nox1)
 NAD(P)H Oxidase 3 (Nox3)
 NAD(P)H Oxidase 4 (Nox4)
 NAD(P)H Oxidase 5 (Nox5)
 Dual Oxidases (Duox1 and...
 Functional Partners of Nox...
Conclusion
 REFERENCES
 
In phagocytic cells, gp91phox is the core catalytic component of a multi-component enzyme complex (1–3). However, p22phox, p47phox, and p67phox are also essential for superoxide production, as is evident in chronic granulomatous disease, where defects or the absence of any one of these components result in oxidase deficiencies. p47phox, a classic adaptor protein, recruits p67phox into the complex, whereas p67phox and Rac appear to regulate catalysis directly (50, 51). An essential role for Rac in oxidase activation was well established in vitro (52) and was later confirmed in an oxidase-deficient patient who expressed mutant Rac2 (53) and in mice deficient in Rac2 (54).

The molecular architectures of the non-phagocytic oxidases are a subject of intense interest, as emerging evidence suggests that some of the closest homologues of gp91phox also function as multicomponent oxidases. Suh et al. (4) originally reported that Nox1 overexpression increases superoxide production although others could not detect superoxide when Nox1 alone was expressed in several hosts (17, 55–57). Interestingly, co-expression of p47phox and p67phox augments superoxide production in cells expressing Nox1 (17, 56). Searching sequence data bases, we identified p41nox, a colon-specific protein homologous to p47phox that was subsequently characterized in several laboratories (55–58). A consensus terminology was recently introduced in which p41nox is designated NAD(P)H oxidase organizer 1 or Noxo1. The mRNA for Noxo1 is detected at high levels within colon crypts, where Nox1 is also expressed (55, 56). The overall homology between p47phox and p41nox is relatively low (27% sequence identity, 46% similarity), although Noxo1 contains all of the functional domains considered essential in its phagocytic counterpart: an N-terminal PX domain, two tandem SH3 domains, and a C-terminal, proline-rich motif that serves as a SH3 domain binding site (55–57). Noxo1 lacks a sequence homologous to the C-terminal "autoinhibitory" domain of p47phox, encompassing a polybasic region with several serines phosphorylated during assembly and activation of the phagocytic oxidase complex (1–3). The PX domain of Noxo1 also lacks the "PXXP" motif seen in p47phox and has a lipid binding specificity that is distinct from that of p47phox (58). Based on these differences, Noxo1 was predicted to adopt a more "open" conformation than p47phox (55–58). Consistent with these distinct features, Noxo1 co-localizes with Nox1 on the plasma membrane when co-expressed in transfected HEK-293 cells, even in the absence of cell stimulation (58).

A protein with remarkable homology to p67phox, p51nox (now called Noxa1 for NADPH oxidase activator 1), was also identified recently in colon epithelium (55–57). Like p67phox, Noxa1 contains four N-terminal tetratricopeptide repeats that bind Rac1, a PB1 domain, and a single, C-terminal SH3 domain that binds p41nox/Noxo1 (55–57). The PB1 domain is less conserved in the mouse sequence (55, 56). The p67phox homologues also contain a short stretch of conserved amino acids following the tetratricopeptide repeats (designated the "activation domain" in p67phox) that is thought to interact with the flavocytochrome complex. Co-expression of Noxo1 and Noxa1 in several Nox1-expressing hosts increases spontaneous (55) and phorbol 12-myristate 13-acetate-induced superoxide production (55, 57). The activity of this multicomponent Nox1-based oxidase is also enhanced by overexpression of p22phox, consistent with other observations showing that Noxo1 and p22phox interact (57). Together, these findings illustrate that the colon oxidase has close structural and functional similarities to the phagocytic enzyme (Fig. 2).



View larger version (41K):
[in this window]
[in a new window]
  		FIG. 2.
Homologous multicomponent Nox family oxidases of phagocytes and colon epithelium. Left, the phagocyte oxidase assembles on newly forming phagosomes, following recruitment of Rac and phosphorylated cytosolic Phox proteins. Right, the Nox1-based oxidase of colon cells comprises some of the same or related cofactors.

 
Nox3 activity is also enhanced in the presence of p47phox and p67phox, Noxo1 and Noxa1, or Noxo1 alone (59), consistent with its close homology to both gp91phox and Nox1. However, the physiologically relevant partners of Nox3 have not been defined. Distinct roles for Noxa1 as a regulator of other Nox/Duox isoforms are possible because its expression is detected in several tissues, notably thyroid and salivary glands, kidney, and pancreas (55, 57). The widespread expression of p22phox may also be indicative of its involvement with other Nox isoforms, particularly Nox4 because this transcript is abundant in kidney (60). An association of p22phox with Duox isoforms is unlikely, however, because p22phox-deficient chronic granulomatous disease patients have no problems in thyroid function. Furthermore, genes homologous to p22phox are not detected in the genome of C. elegans, which encodes Duox genes.3 Rac is another widely expressed candidate modulator of the novel Nox enzymes. Some of the earliest suggestions that NADPH oxidases function in non-myeloid cells were based on observation in cells overexpressing mutant Racs (12, 13); however, there is little evidence confirming that Rac proteins directly regulate the novel Nox enzymes (61). The best direct evidence linking Rac to the non-phagocytic Nox enzymes relates to recent demonstrations of Rac binding to Noxa1 (56); thus, the Nox enzymes regulated by Noxa1, or its homologue p67phox, are prime candidates for modulation by Rac.


   Conclusion
TOP
 INTRODUCTION
 NAD(P)H Oxidase 1 (Nox1)
 NAD(P)H Oxidase 3 (Nox3)
 NAD(P)H Oxidase 4 (Nox4)
 NAD(P)H Oxidase 5 (Nox5)
 Dual Oxidases (Duox1 and...
 Functional Partners of Nox...
 Conclusion
REFERENCES
 
With the recent discovery of new Nox/Duox family members it clear that ROS production in many non-phagocytic cells can originate from multiple, related enzymatic sources. Novel signaling roles for these enzymes have been proposed in a variety of tissues where they are detected at low levels. However, their high levels at other sites, particularly terminally differentiated epithelial cells, suggest that they have other dedicated functions in addition to host defense, such as in hormone biosynthesis, fertilization, oxygen sensing, and extracellular matrix cross-linking. It is likely that ROS-based innate host defense processes are not restricted to phagocytes and that epithelial cells can also use this weapon against invading microbes, particularly along mucosal surfaces. Current challenges are to characterize better the molecular composition of these novel oxidases and to define their precise physiological roles. With recognition of these exciting new functions come the possibilities that these enzymes also have roles in a variety of disease processes related to inappropriate overproduction or underproduction of ROS.


   FOOTNOTES
 
* This minireview will be reprinted in the 2004 Minireview Compendium, which will be available in January, 2005. Back

To whom correspondence should be addressed. Tel.: 301-402-5120; Fax: 301-402-4369; E-mail: tleto{at}nih.gov.

1 The abbreviations used are: ROS, reactive oxygen species; phox, phagocyte oxidase; Nox, NADPH oxidase; LPS, lipopolysaccharide; TLR, toll-like receptor; Noxo1, NADPH oxidase organizer 1; Noxa1, NADPH oxidase activator 1; EPO, erythropoietin. Back

2 Geiszt, M., Lekstrom, K., and Leto, T. (2004) 279, 51661–51668. Back

3 M. Geiszt and T. Leto, unpublished observations. Back


   ACKNOWLEDGMENTS
 
We thank Kristen Lekstrom for providing helpful comments on the manuscript.



   REFERENCES
TOP
 INTRODUCTION
 NAD(P)H Oxidase 1 (Nox1)
 NAD(P)H Oxidase 3 (Nox3)
 NAD(P)H Oxidase 4 (Nox4)
 NAD(P)H Oxidase 5 (Nox5)
 Dual Oxidases (Duox1 and...
 Functional Partners of Nox...
 Conclusion
 REFERENCES
 

  1. Leto, T. L. (1999) in Inflammation Basic Principles and Clinical Correlates (Gallin, J. I., and Snyderman, R., eds) pp. 769–787, Lippincott Williams & Wilkins, Philadelphia
  2. Quinn, M. T., and Gauss, K. A. (2004) J. Leukocyte Biol. 76, 760–781[Abstract/Free Full Text]
  3. Cross, A. R., and Segal, A. W. (2004) Biochim. Biophys. Acta 1657, 1–22
  4. Suh, Y. A., Arnold, R. S., Lassegue, B., Shi, J., Xu, X., Sorescu, D., Chung, A. B., Griendling, K. K., and Lambeth, J. D. (1999) Nature 401, 79–82[CrossRef][Medline] [Order article via Infotrieve]
  5. Geiszt, M., Kopp, J. B., Varnai, P., and Leto, T. L. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 8010–8014[Abstract/Free Full Text]
  6. Dupuy, C., Ohayon, R., Valent, A., Noel-Hudson, M. S., Deme, D., and Virion, A. (1999) J. Biol. Chem. 274, 37265–37269[Abstract/Free Full Text]
  7. De Deken, X., Wang, D., Many, M. C., Costagliola, S., Libert, F., Vassart, G., Dumont, J. E., and Miot, F. (2000) J. Biol. Chem. 275, 23227–23233[Abstract/Free Full Text]
  8. Shiose, A., Kuroda, J., Tsuruya, K., Hirai, M., Hirakata, H., Naito, S., Hattori, M., Sakaki, Y., and Sumimoto, H. (2001) J. Biol. Chem. 276, 1417–1423[Abstract/Free Full Text]
  9. Banfi, B., Molnar, G., Maturana, A., Steger, K., Hegedus, B., Demaurex, N., and Krause, K. H. (2001) J. Biol. Chem. 276, 37594–37601[Abstract/Free Full Text]
  10. Bánfi, B., Maturana, A., Jaconi, S., Arnaudeau, S., Laforge, T., Sinha, B., Ligeti, E., Demaurex, N., and Krause, K. H. (2000) Science 287, 138–142[Abstract/Free Full Text]
  11. Arnold, R. S., Shi, J., Murad, E., Whalen, A. M., Sun, C. Q., Polavarapu, R., Parthasarathy, S., Petros, J. A., and Lambeth, J. D. (2001) Proc. Natl. Acad. Sci. U. S. A. 98, 5550–5555[Abstract/Free Full Text]
  12. Sundaresan, M., Yu, Z.-X., Ferrans, V. J., Irani, K., and Finkel, T. (1995) Science 270, 296–299[Abstract/Free Full Text]
  13. Irani, K., Xia, Y., Zweier, J., Sollott, S., Der, C., Rearon, E., Sundaresan, M., Finkel, T., and Goldschmidt-Clermont, P. (1997) Science 275, 1649–1652[Abstract/Free Full Text]
  14. Szatrowski, T. P., and Nathan, C. F. (1991) Cancer Res. 51, 794–798[Abstract/Free Full Text]
  15. Arbiser, J. L., Petros, J., Klafter, R., Govindajaran, B., McLaughlin, E. R., Brown, L. F., Cohen, C., Moses, M., Kilroy, S., Arnold, R. S., and Lambeth, J. D. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 715–720[Abstract/Free Full Text]
  16. Lambeth, J. D. (2004) Nat. Rev. Immunol. 4, 181–189[CrossRef][Medline] [Order article via Infotrieve]
  17. Geiszt, M., Lekstrom, K., Brenner, S., Hewitt, S. M., Dana, R., Malech, H. L., and Leto, T. L. (2003) J. Immunol. 171, 299–306[Abstract/Free Full Text]
  18. Kawahara, T., Teshima, S., Oka, A., Sugiyama, T., Kishi, K., and Rokutan, K. (2001) Infect. Immun. 69, 4382–4389[Abstract/Free Full Text]
  19. Kawahara, T., Kuwano, Y., Teshima-Kondo, S., Takeya, R., Sumimoto, H., Kishi, K., Tsunawaki, S., Hirayama, T., and Rokutan, K. (2004) J. Immunol. 172, 3051–3058[Abstract/Free Full Text]
  20. Lassegue, B., and Clempus, R. E. (2003) Am. J. Physiol. 285, R277–R297
  21. Lassegue, B., Sorescu, D., Szocs, K., Yin, Q., Akers, M., Zhang, Y., Grant, S. L., Lambeth, J. D., and Griendling, K. K. (2001) Circ. Res. 88, 888–894[Abstract/Free Full Text]
  22. Katsuyama, M., Fan, C., and Yabe-Nishimura, C. (2002) J. Biol. Chem. 277, 13438–13442[Abstract/Free Full Text]
  23. Kikuchi, H., Hikage, M., Miyashita, H., and Fukumoto, M. (2000) Gene (Amst.) 254, 237–243[CrossRef][Medline] [Order article via Infotrieve]
  24. Cheng, G., Cao, Z., Xu, X., van Meir, E. G., and Lambeth, J. D. (2001) Gene (Amst.) 269, 131–140[CrossRef][Medline] [Order article via Infotrieve]
  25. Paffenholz, R., Bergstrom, R. A., Pasutto, F., Wabnitz, P., Munroe, R. J., Jagla, W., Heinzmann, U., Marquardt, A., Bareiss, A., Laufs, J., Russ, A., Stumm, G., Schimenti, J. C., and Bergstrom, D. E. (2004) Genes Dev. 18, 486–491[Abstract/Free Full Text]
  26. Wang, D., Youngson, C., Wong, V., Yeger, H., Dinauer, M. C., Vega-Saenz Miera, E., Rudy, B., and Cutz, E. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 13182–13187[Abstract/Free Full Text]
  27. Loya, F., Yang, Y., Lin, H., Goldwasser, E., and Albitar, M. (1994) Blood 84, 1831–1836[Abstract/Free Full Text]
  28. Elbert, B. L., and Bunn, H. F. (1999) Blood 94, 1864–1877[Free Full Text]
  29. Bruick, R. K. (2003) Genes Dev. 17, 2614–2623[Free Full Text]
  30. Imagawa, S., Yamamoto, M., and Miura, T. (1997) Blood 89, 1430–1439[Abstract/Free Full Text]
  31. Suliman, H. B., Ali, M., and Piantadosi, C. A. (2004) Blood 104, 43–50[Abstract/Free Full Text]
  32. Varma, S. D., and Devamanoharan, P. S. (1990) Free Radic. Res. 8, 73–78
  33. Gorin, Y., Ricono, J. M., Wagner, B., Kim, N. H., Bhandari, B., Ghosh Choudhury, G., and Abboud, H. E. (2004) Biochem. J. 381, 231–239[CrossRef][Medline] [Order article via Infotrieve]
  34. Yang, S., Madyastha, P., Bingel, S., Ries, W., and Key, L. (2001) J. Biol. Chem. 276, 5452–5458[Abstract/Free Full Text]
  35. Ago, T., Kitazono, T., Ooboshi, H., Iyama, T., Han, Y. H., Takada, J., Wakisaka, M., Ibayashi, S., Utsumi, H., and Iida, M. (2004) Circulation 109, 227–233[Abstract/Free Full Text]
  36. Rhee, S. G., Chang, T. S., Bae, Y. S., Lee, S. R., Kang, S. W. (2003) J. Am. Soc. Nephrol. 14, S211–S215[Abstract/Free Full Text]
  37. Mahadev, K., Motoshima, H., Wu, X., Ruddy, J. M., Arnold, R. S., Cheng, G., Lambeth, J. D., and Goldstein, B. J. (2004) Mol. Cell. Biol. 24, 1844–1854[Abstract/Free Full Text]
  38. Banfi, B., Tirone, F., Durussel, I., Knisz, J., Moskwa, P., Molnar, G. Z., Krause, K. H., and Cox, J. A. (2004) J. Biol. Chem. 279, 18583–18591[Abstract/Free Full Text]
  39. Baker, M. A., and Aitken, R. J. (2004) Mol. Cell. Endocrinol. 216, 47–54[CrossRef][Medline] [Order article via Infotrieve]
  40. Devadas, S., Zaritskaya, L., Rhee, S. G., Oberley, L., and Williams, M. S. (2002) J. Exp. Med. 195, 59–70[Abstract/Free Full Text]
  41. Lee, J. R., and Koretzky, G. A. (1998) Eur. J. Immunol. 28, 4188–4197[CrossRef][Medline] [Order article via Infotrieve]
  42. Brar, S. S., Corbin, Z., Kennedy, T. P., Hemendinger, R., Thornton, L., Bommarius, B., Arnold, R. S., Whorton, A. R., Sturrock, A. B., Huecksteadt, T. P., Quinn, M. T., Krenitsky, K., Ardie, K. G., Lambeth, J. D., and Hoidal, J. R. (2003) Am. J. Physiol. 285, C353–C369
  43. Edens, W. A., Sharling, L., Cheng, G., Shapira, R., Kinkade, J. M., Lee, T., Edens, H. A., Tang, X., Sullards, C., Flaherty, D. B., Benian, G. M., and Lambeth, J. D. (2001) J. Cell Biol. 154, 879–891[Abstract/Free Full Text]
  44. Daiyasu, H., and Toh, H. (2000) J. Mol. Evol. 51, 433–445[Medline] [Order article via Infotrieve]
  45. Dupuy, C., Deme, D., Kaniewski, J., Pommier, J., and Virion, A. (1988) FEBS Lett. 233, 74–78
  46. De Deken, X., Wangm, D., Dumont, J. E., and Miot, F. (2002) Exp. Cell Res. 273, 187–196[CrossRef][Medline] [Order article via Infotrieve]
  47. Moreno, J. C., Bikker, H., Kempers, M. J., van Trotsenburg, A. S., Baas, F., de Vijlder, J. J., Vulsma, T., and Ris-Stalpers, C. (2002) N. Engl. J. Med. 347, 95–102[Abstract/Free Full Text]
  48. Geiszt, M., Witta, J., Baffi, J., Lekstrom, K., and Leto, T. L. (2003) FASEB J. 17, 1502–1504[Abstract/Free Full Text]
  49. Reiter, B. A., and Oram, J. D. (1967) Nature 216, 328–330[CrossRef][Medline] [Order article via Infotrieve]
  50. Han, C. H., Freeman, J. L., Lee, T., Motalebi, S. A., and Lambeth, J. D. (1998) J. Biol. Chem. 273, 16663–16668[Abstract/Free Full Text]
  51. Bokoch, G. M., and Knaus, U. G. (2003) Trends Biochem. Sci. 28, 502–508[CrossRef][Medline] [Order article via Infotrieve]
  52. Abo, A., Pick, E., Hall, A., Totty, N., Teahan, C. G., and Segal, A. W. (1991) Nature 353, 668–670[CrossRef][Medline] [Order article via Infotrieve]
  53. Ambruso, D. R., Knall, C., Abell, A. N., Panepinto, J., Kurkchubasche, A., Thurman, G., Gonzalez-Aller, C., Hiester, A., deBoer, M., Harbeck, R. J., Oyer, R., Johnson, G. L., and Roos, D. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 4654–4659[Abstract/Free Full Text]
  54. Roberts, A. W., Kim, C., Zhen, L., Lowe, J. B., Kapur, R., Petryniak, B., Spaetti, A., Pollock, J. D., Borneo, J. B., Bradford, G. B., Atkinson, S. J., Dinauer, M. C., and Williams, D. A. (1999) Immunity 10, 183–196[CrossRef][Medline] [Order article via Infotrieve]
  55. Geiszt, M., Lekstrom, K., Witta, J., and Leto, T. L. (2003) J. Biol. Chem. 278, 20006–20012[Abstract/Free Full Text]
  56. Banfi, B., Clark, R. A., Steger, K., and Krause, K. H. (2003) J. Biol. Chem. 278, 3510–3513[Abstract/Free Full Text]
  57. Takeya, R., Ueno, N., Kami, K., Taura, M., Kohjima, M., Izaki, T., Nunoi, H., and Sumimoto, H. (2003) J. Biol. Chem. 278, 25234–25246[Abstract/Free Full Text]
  58. Cheng, G., and Lambeth, J. D. (2004) J. Biol. Chem. 279, 4737–4742[Abstract/Free Full Text]
  59. Cheng, G., Ritsick, D. R., and Lambeth, J. D. (2004) J. Biol. Chem. 279, 34250–34255[Abstract/Free Full Text]
  60. Sumimoto, H., Nozaki, M., Sasaki, H., Takeshige, K., Sakaki, Y., and Minakami, S. (1989) Biochem. Biophys. Res. Commun. 165, 902–906[CrossRef][Medline] [Order article via Infotrieve]
  61. Park, H. S., Lee, S. H., Park, D., Lee, J. S., Ryu, S. H., Lee, W. J., Rhee, S. G., and Bae, Y. S. (2004) Mol. Cell. Biol. 24, 4384–4394[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Renal Physiol.Home page
H. Liu, Z. Jia, S. Soodvilai, G. Guan, M.-H. Wang, Z. Dong, J. D. Symons, and T. Yang
Nitro-oleic acid protects the mouse kidney from ischemia and reperfusion injury
Am J Physiol Renal Physiol, October 1, 2008; 295(4): F942 - F949.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
X. Y. Shi, F. F. Hou, H. X. Niu, G. B. Wang, D. Xie, Z. J. Guo, Z. M. Zhou, F. Yang, J. W. Tian, and X. Zhang
Advanced Oxidation Protein Products Promote Inflammation in Diabetic Kidney through Activation of Renal Nicotinamide Adenine Dinucleotide Phosphate Oxidase
Endocrinology, April 1, 2008; 149(4): 1829 - 1839.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Choi, T. L. Leto, L. Hunyady, K. J. Catt, Y. S. Bae, and S. G. Rhee
Mechanism of Angiotensin II-induced Superoxide Production in Cells Reconstituted with Angiotensin Type 1 Receptor and the Components of NADPH Oxidase
J. Biol. Chem., January 4, 2008; 283(1): 255 - 267.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
G. Ding, A. Zhang, S. Huang, X. Pan, G. Zhen, R. Chen, and T. Yang
ANG II induces c-Jun NH2-terminal kinase activation and proliferation of human mesangial cells via redox-sensitive transactivation of the EGFR
Am J Physiol Renal Physiol, December 1, 2007; 293(6): F1889 - F1897.
[Abstract] [Full Text] [PDF]

Home page
 Plant CellHome page
H. L. Wong, R. Pinontoan, K. Hayashi, R. Tabata, T. Yaeno, K. Hasegawa, C. Kojima, H. Yoshioka, K. Iba, T. Kawasaki, et al.
Regulation of Rice NADPH Oxidase by Binding of Rac GTPase to Its N-Terminal Extension
PLANT CELL, December 1, 2007; 19(12): 4022 - 4034.
[Abstract] [Full Text] [PDF]

Home page
 Sci SignalHome page
H. Sumimoto, S. Kamakura, and T. Ito
Structure and Function of the PB1 Domain, a Protein Interaction Module Conserved in Animals, Fungi, Amoebas, and Plants
Sci. Signal., August 28, 2007; 2007(401): re6 - re6.
[Abstract] [Full Text] [PDF]

Home page
 ReproductionHome page
K Sabeur and B A Ball
Characterization of NADPH oxidase 5 in equine testis and spermatozoa
Reproduction, August 1, 2007; 134(2): 263 - 270.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. Andriopoulos, S. Hegedusch, J. Mangin, H.-D. Riedel, U. Hebling, J. Wang, K. Pantopoulos, and S. Mueller
Sustained Hydrogen Peroxide Induces Iron Uptake by Transferrin Receptor-1 Independent of the Iron Regulatory Protein/Iron-responsive Element Network
J. Biol. Chem., July 13, 2007; 282(28): 20301 - 20308.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
S. J. Prasanna, B. Saha, and D. Nandi
Involvement of oxidative and nitrosative stress in modulation of gene expression and functional responses by IFN{gamma}
Int. Immunol., July 2, 2007; (2007) dxm058v1.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
E. Babilonia, D. Lin, Y. Zhang, Y. Wei, P. Yue, and W.-H. Wang
Role of gp91phox-Containing NADPH Oxidase in Mediating the Effect of K Restriction on ROMK Channels and Renal K Excretion
J. Am. Soc. Nephrol., July 1, 2007; 18(7): 2037 - 2045.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
A. Orient, A. Donko, A. Szabo, T. L. Leto, and M. Geiszt
Novel sources of reactive oxygen species in the human body
Nephrol. Dial. Transplant., May 1, 2007; 22(5): 1281 - 1288.
[Full Text] [PDF]

Home page
 J. Immunol.Home page
I. Watanabe, M. Ichiki, A. Shiratsuchi, and Y. Nakanishi
TLR2-Mediated Survival of Staphylococcus aureus in Macrophages: A Novel Bacterial Strategy against Host Innate Immunity
J. Immunol., April 15, 2007; 178(8): 4917 - 4925.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
M. Milenkovic, X. De Deken, L. Jin, M. De Felice, R. Di Lauro, J. E Dumont, B. Corvilain, and F. Miot
Duox expression and related H2O2 measurement in mouse thyroid: onset in embryonic development and regulation by TSH in adult
J. Endocrinol., March 1, 2007; 192(3): 615 - 626.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
B. H. Segal, B. A. Davidson, A. D. Hutson, T. A. Russo, B. A. Holm, B. Mullan, M. Habitzruther, S. M. Holland, and P. R. Knight III
Acid aspiration-induced lung inflammation and injury are exacerbated in NADPH oxidase-deficient mice
Am J Physiol Lung Cell Mol Physiol, March 1, 2007; 292(3): L760 - L768.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
U. V. Wesley, P. F. Bove, M. Hristova, S. McCarthy, and A. van der Vliet
Airway Epithelial Cell Migration and Wound Repair by ATP-mediated Activation of Dual Oxidase 1
J. Biol. Chem.,